3D medical printing: throw the dice! – Presented by Ernst-Jan Louwers, Louwers IP|Technology Advocaten at the 3D Medical Conference, which takes place on January 30-31, 2019, at MECC Maastricht, The Netherlands.
New technologies like bioprinting and 3D printing of medical devices, braces etc. may lead to shifting positions and reponsibilities. Players like hospitals may turn into factories but do not realise their changed position.
Ernst-Jan Louwers will discuss the rules of the game in the highly regulated medical market, paradigm shifts and concerns in supply chain, warranties, liabilities and IP. Continue reading “3D medical printing: throw the dice! – Presented by Ernst-Jan Louwers, Louwers IP|Technology Advocaten”
Additive manufacturing to revolutionise personalized regenerative medicine – Holger Jahr, UK RWTH Aachen
Holger Jahr is Secretary-General of the European Orthopaedic Research Society and director of the Orthopaedic research lab at the University Hospital of the RWTH Aachen. He holds an associate professorship in Experimental Orthopaedics and honorary appointments with the Maastricht UMC+ and TU Delft. His research focuses on regenerative biomaterials for musculoskeletal disorders. In 2017, he received the Klee Family Innovation Award for his work on lattice structured 3D-printed metal implants. On January 31, 2018, he will speak during the 3D Medical Printing Conference in Maastricht about Additive manufacturing (resorbable) metal implants for orthopaedic applications
What drives you? Continue reading “Additive manufacturing to revolutionise personalized regenerative medicine – Holger Jahr, UK RWTH Aachen”
From Lab to Life. How Digital Production of Medicines could finally reach the patient – Presented by Tobias Gantner, HealthCare Futurists, at the 3D Medical Conference 2018, which will take place on 30-31 January 2018 at MECC Maastricht, The Netherlands.
Digital Production of Medicines is already quite advanced. The bigger hurdle is to take the regulatory and reimbursement hurdle. In order to prove the added value that this novel technology might bring to patients and caregivers alike, certain requirements will have to be met. This accounts for the overall goals of digital production of medicines as well as to infrastructural necessities that have to be secured such as machinery both on the producer’s and dispenser’s side as well as on the consumer’s part. This talk will discuss how going to market strategies could look like in the light of technological advancements and price deteriorations. We will be looking at changing business models and challenging new approaches such as value-based healthcare in the age of 3D printing of medications. Continue reading “From Lab to Life. How Digital Production of Medicines could finally reach the patient – Presented by Tobias Gantner, HealthCare Futurists”